GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Total Payout Yield %

Rising Biosciences (Rising Biosciences) Total Payout Yield % : 0.00 (As of Jun. 03, 2024)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Rising Biosciences's current Total Payout Yield % is 0.00%.


Rising Biosciences Total Payout Yield % Historical Data

The historical data trend for Rising Biosciences's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Total Payout Yield % Chart

Rising Biosciences Annual Data
Trend
Total Payout Yield %

Rising Biosciences Quarterly Data
Total Payout Yield %

Competitive Comparison of Rising Biosciences's Total Payout Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rising Biosciences's Total Payout Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Total Payout Yield % falls into.



Rising Biosciences Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Rising Biosciences's Total Payout Yield % for the fiscal year that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- ( + + ) /
=N/A%

Rising Biosciences's annualized Total Payout Yield % for the quarter that ended in . 20 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- ( + + ) * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rising Biosciences Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Rising Biosciences Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

Rising Biosciences Set To Acquire All Assets from PAO Group

By Marketwired Marketwired 11-07-2018